Exact Sciences
EXAS
#1383
Rank
โ‚ฌ11.80 B
Marketcap
63,92ย โ‚ฌ
Share price
2.34%
Change (1 day)
-9.27%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ3.14 B

According to Exact Sciences's latest financial reports the company's total liabilities are โ‚ฌ3.14 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ3.00 B1.37%
2022-12-31โ‚ฌ2.96 B2.41%
2021-12-31โ‚ฌ2.89 B31.72%
2020-12-31โ‚ฌ2.20 B102.88%
2019-12-31โ‚ฌ1.08 B47.36%
2018-12-31โ‚ฌ0.73 B1030.06%
2017-12-31โ‚ฌ65.12 M64.1%
2016-12-31โ‚ฌ39.68 M16.55%
2015-12-31โ‚ฌ34.05 M73.87%
2014-12-31โ‚ฌ19.58 M139.2%
2013-12-31โ‚ฌ8.18 M-19.98%
2012-12-31โ‚ฌ10.23 M-1.26%
2011-12-31โ‚ฌ10.36 M-17.97%
2010-12-31โ‚ฌ12.63 M-8.08%
2009-12-31โ‚ฌ13.74 M132.75%
2008-12-31โ‚ฌ5.9 M4.8%
2007-12-31โ‚ฌ5.63 M-16.56%
2006-12-31โ‚ฌ6.75 M-39.51%
2005-12-31โ‚ฌ11.16 M-6.9%
2004-12-31โ‚ฌ11.99 M-33.29%
2003-12-31โ‚ฌ17.97 M60.09%
2002-12-31โ‚ฌ11.22 M139.92%
2001-12-31โ‚ฌ4.67 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ0.31 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ91.86 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.68 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ54.90 B 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France